Table 1.
Outcome of fluticasone nasal spray in smell disorder of COVID-19 patients.
| Odour | Day | Cases (n = 60) |
Controls (n = 60) |
P value Case vs Control day 5 | ||
|---|---|---|---|---|---|---|
| Yes (%) | No (%) | Yes (%) | No (%) | |||
| Musky | Day 1 | 18 (30%) | 42 (70%) | 9 (15%) | 51 (85%) | |
| Day 5 | 56 (93.33%) | 4 (6.67%) | 2 (3.33%) | 58 (96.67%) | <0.001 | |
| P value | <0.0001 | <0.05 (worsened) | ||||
| Pungent | Day 1 | 20 (33.33%) | 40 (66.67%) | 9 (15%) | 51 (85%) | |
| Day 5 | 55 (91.67%) | 5 (8.33%) | 4 (6.67%) | 56 (93.33%) | <0.001 | |
| P value | <0.05 | >0.05 | ||||
| Camphor | Day 1 | 24 (40%) | 36 (60%) | 28 (46.67%) | 32 (53.33%) | |
| Day 5 | 55 (91.67%) | 5 (8.33%) | 6 (10%) | 54 (90%) | <0.001 | |
| P value | <0.05 | <0.05 (worsened) | ||||
| Floral | Day 1 | 5 (8.33%) | 55 (91.67%) | 6 (10%) | 54 (90%) | |
| Day 5 | 53 (88.33%) | 7 (11.67%) | 2 (3.33%) | 58 (96.67%) | <0.001 | |
| P value | <0.05 | >0.05 | ||||
| Mint | Day 1 | 0 (0%) | 60 (100%) | 4 (6.67%) | 56 (93.33%) | |
| Day 5 | 54 (90%) | 6 (10%) | 2 (3.33%) | 58 (96.67%) | <0.001 | |
| P value | <0.001 | >0.05 | ||||